Your browser doesn't support javascript.
loading
Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization.
Li, Jin-Tao; Li, Kai-Yue; Su, Ying; Shen, Yuan; Lei, Ming-Zhu; Zhang, Fan; Yin, Miao; Chen, Zheng-Jun; Wen, Wen-Yu; Hu, Wei-Guo; Su, Dan; Qu, Jia; Lei, Qun-Ying.
Affiliation
  • Li JT; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Li KY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Su Y; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Shen Y; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Lei MZ; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Zhang F; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Yin M; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Chen ZJ; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • Wen WY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Hu WG; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Su D; Cancer Research Institute, Zhejiang Cancer Hospital and Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology of Zhejiang Province, Hangzhou 310022, China.
  • Qu J; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
  • Lei QY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Cancer Institutes; Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Medical Epigenetics; International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Shangh
Natl Sci Rev ; 9(5): nwab212, 2022 May.
Article in En | MEDLINE | ID: mdl-35663242
BCAT2-mediated branched-chain amino acid (BCAA) catabolism is critical for pancreatic ductal adenocarcinoma (PDAC) development, especially at an early stage. However, whether a high-BCAA diet promotes PDAC development in vivo, and the underlying mechanism of BCAT2 upregulation, remain undefined. Here, we find that a high-BCAA diet promotes pancreatic intraepithelial neoplasia (PanIN) progression in LSL-KrasG12D/+ ; Pdx1-Cre (KC) mice. Moreover, we screened with an available deubiquitylase library which contains 31 members of USP family and identified that USP1 deubiquitylates BCAT2 at the K229 site. Furthermore, BCAA increases USP1 protein at the translational level via the GCN2-eIF2α pathway both in vitro and in vivo. More importantly, USP1 inhibition recedes cell proliferation and clone formation in PDAC cells and attenuates pancreas tumor growth in an orthotopic transplanted mice model. Consistently, a positive correlation between USP1 and BCAT2 is found in KC; LSL-KrasG12D/+ ; p53flox/+ ; Pdx1-Cre mice and clinical samples. Thus, a therapeutic targeting USP1-BCAT2-BCAA metabolic axis could be considered as a rational strategy for treatment of PDAC and precisive dietary intervention of BCAA has potentially translational significance.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Natl Sci Rev Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Natl Sci Rev Year: 2022 Type: Article